The Latest Cardiac and Vascular News
OXFORD, England, April 28, 2021 /PRNewswire/ — GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces today a collaboration with Royal Brompton and Harefield hospitals (“RB&H”), recently merged with Guy’s and St Thomas’ NHS Foundation Trust (“GSTT”), to provide globally leading cardiovascular disease clinical genetic […]
Through ACC’s TRANSFORM program, three first-of-a-kind studies will apply implementation science to revolutionize care WASHINGTON, April 28, 2021 /PRNewswire/ — The American College of Cardiology (ACC) and HealthReveal, a leading clinical artificial intelligence company, are collaborating to employ HealthReveal’s personalized clinical AI solution to ACC’s TRANSFORM studies. Through the collaboration, study data […]
Cardiovascular diseases are responsible for 17.9 million deaths every year¹, a third of all deaths globally² Roche announces five new intended uses for key cardiac biomarkers to help identify cardiovascular risk, better diagnose patients and support early treatment Early diagnosis and treatment can contribute to saving or improving people’s lives […]
VANCOUVER and MINNEAPOLIS, April 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced progress towards its value creation strategy of expanding global reimbursement for the Neovasc Reducer™ (“Reducer”). Expanding reimbursement for the Reducer is a key component of Neovasc’s strategy to create shareholder value. In […]
New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2022 Rule SANTA CLARA, CALIF., April 27, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the Centers for Medicare and Medicaid […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies announced the presentation of the First Report of the GUARDIAN Registry1 at the International Society for Heart and Lung Transplantation 2021 Annual Meeting. The GUARDIAN study is the largest multi-center, international registry specifically focused on donor heart preservation. Clinical investigators from the first five enrolling centers collaborated to pool their data and […]
CARE-HK in heart failure (HF) is the first global registry of around 5,000 patients with chronic HF who have or are at high risk for hyperkalemia (HK), in Europe and the US CARE-HK in HF is designed to evaluate the use of Veltassa® in enabling patients to remain on RAASi therapy […]
Online Training Course Aims to Improve Outcomes for Sudden Cardiac Arrest Victims HERNON, Va., April 27, 2021 /PRNewswire/ — Connect For Education Inc. (C4E), a leading provider of online education technologies, is proud to announce a successful launch of Call.Push.Shock, a highly-interactive online training and education curriculum that provides users of all ages […]
– First-of-its-kind outcomes trial designed to assess cardiovascular risk reduction in patients with documented intolerance to statin therapy – – Nearly half of trial participants are women, a significantly higher proportion than have been included in any other previous cardiovascular outcomes study in history – – Event driven MACE (major […]
The new name reflects the company’s commitment to pediatric, critical care, and chronic heart failure patients EDEN PRAIRIE, Minn., April 27, 2021 (GLOBE NEWSWIRE) — Company names are reflective of the services provided to its customers, and CHF Solutions – a leader and pioneer in the heart failure space – […]
